GlassScriptPhysician profile
Charles William Titone
NPI 1619930120
$3,454.81
in general payments reported to CMS, 2019-2025
15 companies · $821 in 2025
The $821 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,095 · 2020: $172 · 2021: $64.63 · 2022: $140 · 2023: $111 · 2024: $52.08 · 2025: $821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $984.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $983.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $2,035.38 | 2019-2025 | Tecnis Iol, Tecnis Iol |
| Alcon Vision LLC | $362.34 | 2021-2025 | Clareon Panoptix Pro, Clareon, Rocklatan |
| Bausch & Lomb Americas INC. | $273.45 | 2025 | Vyzulta, Xiidra, Miebo |
| Carl Zeiss Meditec, INC. | $141.42 | 2019-2023 | |
| Horizon Therapeutics Plc | $125.00 | 2022 | |
| Aerie Pharmaceuticals, INC. | $101.60 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $100.01 | 2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $76.15 | 2019 | |
| Allergan, INC. | $63.78 | 2020 | |
| Rxsight INC | $57.97 | 2024-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Glaukos Corporation | $55.01 | 2020 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Ivantis, INC | $16.20 | 2020 | |
| Carl Zeiss Meditec Digital Innovations LLC | $14.24 | 2019 | |
| Dompe US, INC. | $12.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Titone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.